| 1 |
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc. |
1:25-cv-00003 |
N.D.W.Va. |
|
|
|
|
| 2 |
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc. |
1:25-cv-00003 |
N.D.W.Va. |
|
|
|
|
| 3 |
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc. |
1:24-cv-00036 |
N.D.W.Va. |
|
|
|
|
| 4 |
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc. |
1:24-cv-00036 |
N.D.W.Va. |
|
|
|
|
| 5 |
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc. |
1:24-cv-00050 |
D.Del. |
|
|
|
|
| 6 |
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc. |
1:24-cv-00050 |
D.Del. |
|
|
|
|
| 7 |
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc. |
1:24-cv-00043 |
D.Del. |
|
|
|
|
| 8 |
Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc. |
1:23-cv-00088 |
N.D.W.Va. |
|
|
|
|
| 9 |
Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc. |
1:23-cv-00088 |
N.D.W.Va. |
|
|
|
|
| 10 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 11 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 12 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 13 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
| 14 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
| 15 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
| 16 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
| 17 |
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al |
1:20-md-00445 |
D.Del. |
|
|
|
|
| 18 |
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-03168 |
D.N.J. |
|
|
|
|
| 19 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
| 20 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
| 21 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
| 22 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
| 23 |
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-02749 |
D.N.J. |
|
|
|
|
| 24 |
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-02749 |
D.N.J. |
|
|
|
|
| 25 |
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-02749 |
D.N.J. |
|
|
|
|
| 26 |
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al |
3:20-cv-02749 |
D.N.J. |
|
|
|
|
| 27 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
| 28 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
| 29 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
| 30 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
| 31 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00202 |
N.D.W.Va. |
|
|
|
|
| 32 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-01699 |
D.Del. |
|
|
|
|
| 33 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
| 34 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
| 35 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
| 36 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
| 37 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00217 |
N.D.W.Va. |
|
|
|
|
| 38 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
| 39 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
| 40 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
| 41 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
| 42 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
| 43 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
| 44 |
Indivior Inc. et al v. Mylan Technologies Inc. et al |
1:17-cv-00157 |
N.D.W.Va. |
|
|
|
|
| 45 |
Indivior Inc. et al v. Mylan Technologies Inc. et al |
1:17-cv-00157 |
N.D.W.Va. |
|
|
|
|
| 46 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:17-cv-03387 |
D.N.J. |
|
|
|
|
| 47 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 48 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 49 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 50 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00036 |
N.D.W.Va. |
|
|
|
|